Merus NV (MRUS)
51.18
-0.04
(-0.08%)
USD |
NASDAQ |
Nov 05, 14:35
Merus Profit Margin (Quarterly): -848.7% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -848.7% |
| June 30, 2024 | -682.5% |
| March 31, 2024 | -436.8% |
| December 31, 2023 | -672.9% |
| September 30, 2023 | -208.6% |
| June 30, 2023 | -305.8% |
| March 31, 2023 | -294.4% |
| December 31, 2022 | -768.5% |
| September 30, 2022 | -374.0% |
| June 30, 2022 | -45.05% |
| March 31, 2022 | -162.1% |
| December 31, 2021 | -98.04% |
| September 30, 2021 | -108.7% |
| June 30, 2021 | -221.2% |
| March 31, 2021 | -121.6% |
| December 31, 2020 | -310.2% |
| September 30, 2020 | -269.3% |
| June 30, 2020 | -296.8% |
| March 31, 2020 | -261.9% |
| December 31, 2019 | -326.3% |
| September 30, 2019 | -113.6% |
| Date | Value |
|---|---|
| June 30, 2019 | -210.4% |
| March 31, 2019 | -80.22% |
| December 31, 2018 | -6.32% |
| September 30, 2018 | -164.5% |
| June 30, 2018 | -71.44% |
| March 31, 2018 | -85.59% |
| December 31, 2017 | -216.8% |
| September 30, 2017 | -236.1% |
| June 30, 2017 | -360.0% |
| March 31, 2017 | -513.0% |
| December 31, 2016 | |
| September 30, 2016 | -554.4% |
| June 30, 2016 | -2.54K% |
| March 31, 2016 | -9.75K% |
| December 31, 2015 | -32.00K% |
| September 30, 2015 | -6.33K% |
| June 30, 2015 | -503.0% |
| March 31, 2015 | -8.63K% |
| December 31, 2014 | -1.33K% |
| September 30, 2014 | -1.30K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-848.7%
Minimum
Sep 2024
-45.05%
Maximum
Jun 2022
-340.7%
Average
-295.6%
Median
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -506.0% |
| ProQR Therapeutics NV | -42.70% |
| argenx SE | 15.95% |
| Pharming Group | -1.38% |
| Pharvaris NV | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.97% |
| Return on Assets | -38.42% |
| Return on Invested Capital | -47.97% |
| Operating Margin (Quarterly) | -613.6% |
| Return on Net Operating Assets | -452.2% |